Clinical Trials Browser

OTHER × Adenocarcinoma × aumolertinib × Clear all

NCT04401059 2023-12-27

SELECT-2

Phase 4 Recruiting

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung